Artwork

Content provided by Charles Ryan MD, Alicia Morgans MD MPH, Charles Ryan MD, and Alicia Morgans MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Charles Ryan MD, Alicia Morgans MD MPH, Charles Ryan MD, and Alicia Morgans MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Story Behind Imatinib, the First Targeted Cancer Treatment

26:59
 
Share
 

Manage episode 480837289 series 3636749
Content provided by Charles Ryan MD, Alicia Morgans MD MPH, Charles Ryan MD, and Alicia Morgans MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Charles Ryan MD, Alicia Morgans MD MPH, Charles Ryan MD, and Alicia Morgans MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Before the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new era of cancer treatment, with drugs that directly target tumor cells. In this episode, Chuck and Alicia talk with Dr. Brian Druker, a renowned physician scientist who was the main force behind the development of Imatinib.

  continue reading

11 episodes

Artwork
iconShare
 
Manage episode 480837289 series 3636749
Content provided by Charles Ryan MD, Alicia Morgans MD MPH, Charles Ryan MD, and Alicia Morgans MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Charles Ryan MD, Alicia Morgans MD MPH, Charles Ryan MD, and Alicia Morgans MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Before the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new era of cancer treatment, with drugs that directly target tumor cells. In this episode, Chuck and Alicia talk with Dr. Brian Druker, a renowned physician scientist who was the main force behind the development of Imatinib.

  continue reading

11 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play